Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Neuroprotection Program
Cardioprotection Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
13-Oct-2023
Quarterly Activities Report and Appendix 4C
28-Aug-2023
Nyrada Full Year Results FY2023
28-Aug-2023
Annual Report for year ended 30 June 2023
28-Aug-2023
Preliminary Final Report
28-Aug-2023
Appendix 4G and Corporate Governance Statement
28-Jul-2023
Quarterly Activities Report and Appendix 4C
20-Jul-2023
Nyrada Review of Operating Costs
26-Jun-2023
Cholesterol-Lowering Program Update
9-Jun-2023
Brain Injury Program Preclinical Development Update
26-May-2023
Cholesterol-Lowering Program Preclinical Studies Completed
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Next